OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
41 hedge funds and large institutions have $46M invested in Ocera Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$665K | |
| 2 | +$637K | |
| 3 | +$397K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$180K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$119K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$933K | |
| 3 | -$365K | |
| 4 |
Millennium Management
New York
|
-$365K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$260K |